Telescope Innovations Corp. (CSE:TELI)
Canada flag Canada · Delayed Price · Currency is CAD
0.2450
-0.0300 (-9.38%)
May 9, 2025, 11:45 AM EDT
-24.62%
Market Cap 13.15M
Revenue (ttm) 4.45M
Net Income (ttm) -2.05M
Shares Out 53.67M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 118,000
Average Volume 95,277
Open 0.2450
Previous Close 0.2450
Day's Range 0.2450 - 0.2450
52-Week Range 0.2450 - 0.5500
Beta 1.59
RSI 39.16
Earnings Date Apr 23, 2025

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. is based in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Henry Dubina
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol TELI
Full Company Profile

Financial Performance

In 2024, Telescope Innovations's revenue was 4.43 million, an increase of 56.80% compared to the previous year's 2.82 million. Losses were -1.32 million, 84.3% more than in 2023.

Financial Statements

News

There is no news available yet.